# MAP Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/map-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Mountain View, US
- Website: www.mappharma.com
- Total disclosed funding: $105M
- Latest round: Series D (Mar 27, 2007)
- Investors on record: 7

## About

Founded in 2003.MAP Pharmaceuticals is based in Mountain View, US and is an innovative drug company focused on providing better treatments for patients with neurological diseases.

## Funding rounds

- Series D, Mar 27, 2007, $50M — Perseus, Skyline Ventures, Brookside Capital Partners, D. E. Shaw & Co, FirstMark Capital
- Series C, Jan 25, 2006, $25M — Perseus, Skyline Ventures, Brookside Capital Partners, Alexandria Venture Investments, Bay City Capital, FirstMark Capital
- Series B, Sep 7, 2004, $30M — Perseus, Skyline Ventures, Bay City Capital, FirstMark Capital

## Investors

- Perseus (https://capitalatlas.ai/funds/perseus) — Series B, Series C, Series D
- Skyline Ventures (https://capitalatlas.ai/funds/skyline-ventures) — Series B, Series C, Series D
- Bay City Capital (https://capitalatlas.ai/funds/bay-city-capital) — Series B, Series C
- FirstMark Capital (https://capitalatlas.ai/funds/firstmark-capital) — Series B, Series C, Series D
- Brookside Capital Partners (https://capitalatlas.ai/funds/brookside-capital-partners) — Series C, Series D
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series C
- D. E. Shaw & Co (https://capitalatlas.ai/funds/d-e-shaw-co) — Series D